Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice

Arie Apel*, Yakir Moshe, Yishai Ofran, Alexander Gural, Ofir Wolach, Chezi Ganzel, Jonathan Canaani, Miri Zektser, Adrian Duek, Galia Stemer, Ilana Hellman, May Basood, Avraham Frisch, Chiya Leibovitch, Maya Koren-Michowitz

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

23 Scopus citations

Fingerprint

Dive into the research topics of 'Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice'. Together they form a unique fingerprint.

Keyphrases

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science